Daré Bioscience, Inc.
DARE
$0.72
$0.011.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 40.94% | -617.02% | -230.55% | -384.47% | -158.33% |
| Total Depreciation and Amortization | 231.79% | 877.84% | 3,791.49% | 2,335.95% | 1,319.56% |
| Total Amortization of Deferred Charges | 47.03% | -1,557.14% | -- | 367.58% | -200.00% |
| Total Other Non-Cash Items | -10.06% | -17.07% | -41.82% | 3.24% | 5.06% |
| Change in Net Operating Assets | -219.50% | -137.71% | -103.58% | 213.77% | 173.93% |
| Cash from Operations | 1.85% | -245.77% | -280.61% | 24.80% | -14.36% |
| Capital Expenditure | -62.41% | 68.48% | 32.77% | -20.06% | 69.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -62.41% | 68.48% | 32.77% | -20.06% | 69.15% |
| Total Debt Issued | -13.35% | -13.35% | -13.35% | -13.35% | -6.57% |
| Total Debt Repaid | -158.38% | -378.78% | -213.88% | -149.19% | -69.74% |
| Issuance of Common Stock | 1,997.90% | 2,951.53% | 4,514.20% | 1,564.90% | -89.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -337.75% | -317.41% | -294.72% | -101.69% | -101.69% |
| Cash from Financing | 4,412.74% | 3,019.57% | 5,337.83% | 217.30% | -96.95% |
| Foreign Exchange rate Adjustments | 261.27% | 347.44% | 110.60% | -158.52% | -191.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.63% | 22.89% | 73.76% | 539.12% | -473.02% |